Bansal Y - Search Results

1

A critical analysis of design, binding pattern and SAR of benzo-fused heteronuclear compounds as VEGFR-2 inhibitors.

Kashyap M, Gupta S, Bansal Y, Bansal G. Kashyap M, et al. Among authors: bansal y. Bioorg Med Chem. 2024 Dec 1;115:117966. doi: 10.1016/j.bmc.2024.117966. Epub 2024 Oct 22. Bioorg Med Chem. 2024. PMID: 39488171 Review.

2

Design, synthesis, and evaluation of novelly substituted benzimidazole compounds as angiotensin II receptor antagonists.

Bali A, Bansal Y, Sugumaran M, Saggu JS, Balakumar P, Kaur G, Bansal G, Sharma A, Singh M. Bali A, et al. Among authors: bansal g, bansal y. Bioorg Med Chem Lett. 2005 Sep 1;15(17):3962-5. doi: 10.1016/j.bmcl.2005.05.054. Bioorg Med Chem Lett. 2005. PMID: 16039125

3

Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.

Shah DI, Sharma M, Bansal Y, Bansal G, Singh M. Shah DI, et al. Among authors: bansal g, bansal y. Eur J Med Chem. 2008 Sep;43(9):1808-12. doi: 10.1016/j.ejmech.2007.11.008. Epub 2007 Nov 22. Eur J Med Chem. 2008. PMID: 18158200

4

Design, synthesis, and evaluation of 5-sulfamoyl benzimidazole derivatives as novel angiotensin II receptor antagonists.

Kaur N, Kaur A, Bansal Y, Shah DI, Bansal G, Singh M. Kaur N, et al. Among authors: bansal g, bansal y. Bioorg Med Chem. 2008 Dec 15;16(24):10210-5. doi: 10.1016/j.bmc.2008.10.056. Epub 2008 Oct 29. Bioorg Med Chem. 2008. PMID: 19013821 Free PMC article.

5

MS2/TOF and LC-MS/TOF studies on toremifene to characterize its forced degradation products.

Bansal G, Maddhesia PK, Bansal Y. Bansal G, et al. Among authors: bansal y. Analyst. 2011 Dec 21;136(24):5218-28. doi: 10.1039/c1an15587c. Epub 2011 Oct 19. Analyst. 2011. PMID: 22013582

6

ESI-MSn and LC-ESI-MS studies to characterize forced degradation products of bosentan and a validated stability-indicating LC-UV method.

Bansal G, Singh R, Saini B, Bansal Y. Bansal G, et al. Among authors: bansal y. J Pharm Biomed Anal. 2013 Jan;72:186-97. doi: 10.1016/j.jpba.2012.08.014. Epub 2012 Sep 2. J Pharm Biomed Anal. 2013. PMID: 22999302

7

The therapeutic journey of benzimidazoles: a review.

Bansal Y, Silakari O. Bansal Y, et al. Bioorg Med Chem. 2012 Nov 1;20(21):6208-36. doi: 10.1016/j.bmc.2012.09.013. Epub 2012 Sep 17. Bioorg Med Chem. 2012. PMID: 23031649 Review.

8

Design, synthesis and PASS assisted evaluation of novel 2-substituted benzimidazole derivatives as potent anthelimintics.

Singh G, Bansal Y, Bansal G, Goel RK. Singh G, et al. Among authors: bansal g, bansal y. Med Chem. 2014 Jun;10(4):418-25. doi: 10.2174/157340641004140421115518. Med Chem. 2014. PMID: 23627317

9

MS(n) , LC-MS-TOF and LC-PDA studies for identification of new degradation impurities of bupropion.

Bansal R, Saini B, Bansal Y, Bansal G. Bansal R, et al. Among authors: bansal g, bansal y. Biomed Chromatogr. 2013 Nov;27(11):1387-97. doi: 10.1002/bmc.2933. Epub 2013 Jun 24. Biomed Chromatogr. 2013. PMID: 23798322

10

Coumarin hybrids as novel therapeutic agents.

Sandhu S, Bansal Y, Silakari O, Bansal G. Sandhu S, et al. Among authors: bansal g, bansal y. Bioorg Med Chem. 2014 Aug 1;22(15):3806-14. doi: 10.1016/j.bmc.2014.05.032. Epub 2014 May 22. Bioorg Med Chem. 2014. PMID: 24934993 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters